DE60025807D1 - Transdermale zusammenstellung eines antibrechmittelsund eine zubereitung die dasselbe enthält - Google Patents

Transdermale zusammenstellung eines antibrechmittelsund eine zubereitung die dasselbe enthält

Info

Publication number
DE60025807D1
DE60025807D1 DE60025807T DE60025807T DE60025807D1 DE 60025807 D1 DE60025807 D1 DE 60025807D1 DE 60025807 T DE60025807 T DE 60025807T DE 60025807 T DE60025807 T DE 60025807T DE 60025807 D1 DE60025807 D1 DE 60025807D1
Authority
DE
Germany
Prior art keywords
transdermale
antibody
preparation
composition
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025807T
Other languages
English (en)
Other versions
DE60025807T2 (de
Inventor
Bo Youn Seo
Joong Woong Cho
Young Kweon Choi
Jun Seok Hwang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samyang Biopharmaceuticals Corp
Original Assignee
Samyang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Corp filed Critical Samyang Corp
Application granted granted Critical
Publication of DE60025807D1 publication Critical patent/DE60025807D1/de
Publication of DE60025807T2 publication Critical patent/DE60025807T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60025807T 1999-02-09 2000-02-09 Transdermale zusammenstellung eines antibrechmittels und eine zubereitung die dasselbe enthält Expired - Lifetime DE60025807T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR9904500 1999-02-09
KR19990004500 1999-02-09
PCT/KR2000/000096 WO2000047208A1 (en) 1999-02-09 2000-02-09 A transdermal composition of an antivomiting agent and a preparation containing the same

Publications (2)

Publication Number Publication Date
DE60025807D1 true DE60025807D1 (de) 2006-04-13
DE60025807T2 DE60025807T2 (de) 2006-08-17

Family

ID=36746247

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025807T Expired - Lifetime DE60025807T2 (de) 1999-02-09 2000-02-09 Transdermale zusammenstellung eines antibrechmittels und eine zubereitung die dasselbe enthält

Country Status (8)

Country Link
EP (1) EP1150675B1 (de)
JP (1) JP4271869B2 (de)
CN (1) CN1209108C (de)
AU (1) AU2577500A (de)
CA (1) CA2360300C (de)
DE (1) DE60025807T2 (de)
ES (1) ES2261178T3 (de)
WO (1) WO2000047208A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100390870B1 (ko) * 1999-02-09 2003-07-10 주식회사 삼양사 경피투여용 항구토제 조성물 및 이를 포함하는 제제
GB9917290D0 (en) * 1999-07-22 1999-09-22 Glaxo Wellcome Spa Pharmaceutical composition
DE10110953A1 (de) * 2001-03-07 2002-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten
IL152573A (en) 2002-10-31 2009-11-18 Transpharma Medical Ltd A system for the transmission through the skin of a medical preparation against vomiting and nausea
IL152575A (en) 2002-10-31 2008-12-29 Transpharma Medical Ltd A skin-to-skin transmission system of water-insoluble drugs
AU2003279578A1 (en) * 2002-12-13 2004-07-09 Samyang Corporation Transdermal composition of an antivomiting agent
GB0302662D0 (en) * 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron
EP1784150A4 (de) * 2004-09-01 2011-05-11 Nexmed Holdings Inc Transdermales antiemese-abgabesystem, verfahren und zusammensetzung dafür
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
DE112008002414A5 (de) 2007-07-04 2010-06-10 Acino Ag Reservoirsystem mit verschlossener Membran
EP2286814B1 (de) 2008-05-15 2013-10-16 Hisamitsu Pharmaceutical Co., Inc. Transdermale zubereitung mit palonosetron
WO2010050423A1 (ja) * 2008-10-27 2010-05-06 日本臓器製薬株式会社 オンダンセトロン含有外用医薬組成物
TW201021856A (en) * 2008-12-01 2010-06-16 Genovate Biotechnology Co Ltd Antiemetic patch
ES2673219T3 (es) 2010-11-15 2018-06-20 Neuroderm Ltd Composición para la entrega transdérmica de agentes activos
JP6434408B2 (ja) 2012-08-24 2018-12-05 インテグアールエックス セラピューティクス， エルエルシーＩｎｔｅｇｕｒｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｌｌｃ 治療剤の経皮送達を増強するための化学組成物および方法
JP7032037B2 (ja) * 2013-02-27 2022-03-08 ロバート バット ローリー 経皮製剤
CA2968046A1 (en) * 2014-12-23 2016-06-30 Steven Hoffman Transdermal formulations
CA3116899A1 (en) * 2018-10-24 2020-04-30 Somnio Global Holdings, Llc Functional wound healing dressings
CN114617859A (zh) * 2022-03-28 2022-06-14 烟台大学 盐酸托烷司琼醇质体凝胶贴膏及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2153882A1 (en) * 1993-01-21 1994-08-04 Masataka Katsuma Novel transdermal absorption preparation
US5908619A (en) * 1997-01-09 1999-06-01 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
US6019997A (en) * 1997-01-09 2000-02-01 Minnesota Mining And Manufacturing Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
WO1998053815A1 (en) * 1997-05-30 1998-12-03 Minnesota Mining And Manufacturing Company Transdermal drug delivery device for the delivery of tropisetron or granisetron

Also Published As

Publication number Publication date
DE60025807T2 (de) 2006-08-17
CN1209108C (zh) 2005-07-06
ES2261178T3 (es) 2006-11-16
CA2360300A1 (en) 2000-08-17
CN1364083A (zh) 2002-08-14
WO2000047208A1 (en) 2000-08-17
JP2002536412A (ja) 2002-10-29
JP4271869B2 (ja) 2009-06-03
CA2360300C (en) 2008-08-26
AU2577500A (en) 2000-08-29
EP1150675A1 (de) 2001-11-07
EP1150675B1 (de) 2006-02-01

Similar Documents

Publication Publication Date Title
DE60025807D1 (de) Transdermale zusammenstellung eines antibrechmittelsund eine zubereitung die dasselbe enthält
DE69531318D1 (de) Shampoozusammensetzung
DE60024594D1 (de) Ophthalmologische zubereitung die mucin enthält
FR2718350B1 (fr) Compositions cosmétiques à appliquer sur l'ongle.
DE69904677T2 (de) Zusammensetzung, die ein Trübungs- oder Perlglanzmittel und mindestens einen Fettalkohol enthält
DE69300913T2 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
CY2009017I1 (el) Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
EE05020B1 (et) Glburiidi ravimkoostis
GB9927332D0 (en) Novel antibody and uses thereof
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
DE69007908D1 (de) Shampoo-Zusammensetzung.
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
BR9509688A (pt) Composto e composição farmacêutica
DE69907047D1 (de) Styrolharz und Harzzusammensetzung, die solche enthält
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
DE69811651T2 (de) Enthaarungszusammensetzungen, die bereitung und die verwendung derselben
DE60016867D1 (de) Topische Zusammensetzung für die Haut und deren Anwendung
DE69413111D1 (de) Shampoozusammensetzung
GB2364640B (en) Anti-ulcer pharmaceutical composition and the preparation thereof
FR2795928B1 (fr) Article pour l'application d'une composition topique et son procede de preparation
PT1181290E (pt) Polimorfos de um citrato cristalino de azobiciclo¬2,2,2|octan-3-amina e suas composicoes farmaceuticas
FI990736A (fi) Suoja- tai säilöntäainekoostumus, sen valmistusmenetelmä sekä sen käyttö
IT249804Y1 (it) Astuccio per cosmetici dotato di mezzi per l'applicazione di prodottipastosi e simili
IT1319672B1 (it) Lubrificante solido, in particolare per la preparazione di materialid'attrito, procedimento per la sua realizzazione e materiali d'attrito

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1150675

Country of ref document: EP

Representative=s name: ISARPATENT, DE

R081 Change of applicant/patentee

Ref document number: 1150675

Country of ref document: EP

Owner name: SAMYANG BIOPHARMACEUTICALS CORP., KR

Free format text: FORMER OWNER: SAMYANG CORP., SEOUL/SOUL, KR

Effective date: 20120813

R082 Change of representative

Ref document number: 1150675

Country of ref document: EP

Representative=s name: ISARPATENT GBR PATENT- UND RECHTSANWAELTE, DE

Effective date: 20120813